# Sensus Healthcare, Inc (SRTS)

> Sensus Healthcare, Inc (SRTS) trades at $2.26 (-4.24%) as of 4:10:04 PM EST on Nov 20, 2026, -21.25% over the past month. Market cap is $38.85M, with 7.2 days to cover in short interest.

Canonical: https://massive.com/quote/srts
Data as of: 2026-11-20T21:10:04.556Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$2.26** -0.10 (-4.24%)
As of 4:10:04 PM EST on Nov 20, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Sensus Healthcare, Inc (SRTS) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -4.24% |
| 1W | -2.80% |
| 1M | -21.25% |
| YTD | -43.22% |
| 1Y | -43.78% |
| 52-wk range | $2.14 – $5.49 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for SRTS: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $2.19 – $2.41 |
| Open | $2.39 |
| Prev close | $2.36 |
| Volume | 122.02K |
| Market cap | $38.85M |
| Shares out | 16.46M |

## Valuation and profitability ratios

Valuation and profitability ratios for Sensus Healthcare, Inc: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 2.34 |
| P/B | 1.10 |
| P/FCF | — |
| ROE | -45.3% |
| ROA | -39.5% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 19, 2026

## Insider trading

[Sensus Healthcare, Inc (SRTS) insider trading](https://massive.com/quote/srts/insider-trading.md): open-market Form 4 buys and sells by Sensus Healthcare, Inc insiders over the last 12 months.

## 8-K filings

Material corporate events Sensus Healthcare, Inc has disclosed to the SEC on Form 8-K.

- Nov 12, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 12, 2026, Sensus Healthcare, Inc. announced via press release its financial results for the third quarter of 2026.”
- Jun 5, 2026 · Credit facility
  “On June 2, 2026, Sensus Healthcare, Inc. (the "Company") entered into a Loan Agreement (the "Loan Agreement") with City National Bank of Florida ("CNB") pursuant to which CNB has made available to the Company a revolving credit facility providing for maximum borrowings of $15,000,000 (the "Loan"), which is evidenced by a Revolving Promissory Note, dated June 2, 2026 (the "Note"), made by the Company in favor of CNB. Pursuant to the terms of the Note, advances made under the Loan bear interest at the Secured Overnight Financing Rate plus 3% per annum and have a maturity date of June 5, 2027 unless extended by mutual agreement of the Company and CNB.”
- Jun 2, 2026 · Annual meeting results
  “Eric Sachetta and Michael J. Sardano were elected as Class II directors for a three-year term to expire in 2029. Each nominee was an incumbent director, and no other person was nominated.”
- Jan 20, 2026 · [New auditor engagement](https://massive.com/quote/sec-filings/8-k/auditor-changes.md)
  “On January 13, 2026, the Audit Committee of the Company's Board of Directors simultaneously dismissed BPB as the Company's independent registered public accounting firm and approved the appointment of CRI as the Company's independent registered public accounting firm.”
- Nov 13, 2025 · Director departure
  “Mr. Sachetta fills a vacancy resulting from the death of William McCall.”

## SRTS short interest

How heavily SRTS is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 7.2 |
| Short interest | 222.27K |
| Avg volume | 30.91K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## SRTS news

The latest news and headlines about Sensus Healthcare, Inc (SRTS).

- [MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders](https://www.globenewswire.com/news-release/2025/10/09/3164462/0/en/MAREX-REMINDER-Bragar-Eagel-Squire-P-C-Reminds-Marex-Group-Investors-to-Contact-the-Firm-Regarding-Ongoing-Investigation-on-Behalf-of-Marex-Stockholders.html) · GlobeNewswire Inc. · Oct 9, 2025 · negative sentiment
- [SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders](https://www.globenewswire.com/news-release/2025/10/09/3164456/0/en/SENSUS-INVESTIGATION-REMINDER-Bragar-Eagel-Squire-Reminds-Sensus-Healthcare-Investors-to-Contact-the-Firm-Regarding-Ongoing-Investigation-on-Behalf-of-Sensus-Stockholders.html) · GlobeNewswire Inc. · Oct 9, 2025 · negative sentiment
- [AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders](https://www.globenewswire.com/news-release/2025/10/09/3164453/0/en/AVITA-REMINDER-Bragar-Eagel-Squire-P-C-Reminds-AVITA-Medical-Investors-to-Contact-the-Firm-Regarding-the-Ongoing-Investigation-on-Behalf-of-Stockholders.html) · GlobeNewswire Inc. · Oct 9, 2025 · negative sentiment
- [SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm](https://www.globenewswire.com/news-release/2025/08/31/3141913/0/en/SENSUS-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-Sensus-Healthcare-Inc-on-Behalf-of-Sensus-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html) · GlobeNewswire Inc. · Aug 31, 2025 · negative sentiment
- [Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm](https://www.globenewswire.com/news-release/2025/08/28/3141081/0/en/Sensus-Healthcare-Inc-Investors-Company-Investigated-by-the-Portnoy-Law-Firm.html) · GlobeNewswire Inc. · Aug 28, 2025 · negative sentiment

## About Sensus Healthcare, Inc

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 60 |
| Listed | Jul 25, 2016 |

[Company website](https://www.sensushealthcare.com)

## FAQ

### What is the Sensus Healthcare, Inc (SRTS) stock price today?

Sensus Healthcare, Inc (SRTS) is trading at $2.26 (-4.24% on the day) as of 4:10:04 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Sensus Healthcare, Inc?

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids.

### What is the short interest in SRTS?

As of Oct 30, 2026, SRTS has 222.27K shares short and 7.2 days to cover.

### What exchange is SRTS listed on?

Sensus Healthcare, Inc (SRTS) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time SRTS quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=SRTS`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Sensus Healthcare, Inc (SRTS) insider trading](https://massive.com/quote/srts/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
